Lianbao Kong

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Nanjing Medical University

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Research Subjects

Research Interests

Lianbao Kong has a total of 179 co-authors. Here are the top co-authors by number of shared publications:

Deming Zhu
18 shared publications
Chengdian Rao
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
15 shared publications
Chenxi Wang
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
15 shared publications
Jinyi Wang
Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China; Department of Hepatobiliary and Pancreatic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, National Health Commission (NHC) Key Laboratory of Hepatobiliary Cancers, Nanjing, Jiangsu Province, China
15 shared publications
Kai Zhao
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Department of Physiology, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
15 shared publications
Lulu Zhang
Department of Clinical Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, China
15 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
A novel combination strategy co-targeting the USP7-FGFR4 axis and standard therapies for HCC.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 10 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
A novel combination strategy co-targeting the USP7-FGFR4 axis and standard therapies for HCC.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 enhances stemness features and confers resistance to standard therapy in HCC cells in vitro.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 2 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 enhances stemness features and confers resistance to standard therapy in HCC cells in vitro.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 enhances stemness features and confers resistance to standard therapy in HCC cells in vivo.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 3 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 enhances stemness features and confers resistance to standard therapy in HCC cells in vivo.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 potentiates tumorgenesis and drug resistance of HCC in both liver-specific SEPTIN7 knockout mice and patient-derived organoids.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 4 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 potentiates tumorgenesis and drug resistance of HCC in both liver-specific SEPTIN7 knockout mice and patient-derived organoids.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 inhibits K48-linked ubiquitin-mediated proteasomal degradation of FGFR4 by facilitating the recruitment of USP7.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 6 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 inhibits K48-linked ubiquitin-mediated proteasomal degradation of FGFR4 by facilitating the recruitment of USP7.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 promotes HCC stemness and therapeutic resistance by enhancing the stability and signaling activity of FGFR4.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 5 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 promotes HCC stemness and therapeutic resistance by enhancing the stability and signaling activity of FGFR4.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 promotes HCC stemness and therapeutic resistance via a RACK1-dependent mechanism, which facilitates FGFR4 phosphorylation at S440 site.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 8 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
SEPTIN7 promotes HCC stemness and therapeutic resistance via a RACK1-dependent mechanism, which facilitates FGFR4 phosphorylation at S440 site.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
RACK1 facilitates FGFR4 phosphorylation at S440 site.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 7 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
RACK1 facilitates FGFR4 phosphorylation at S440 site.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
A phosphorylation-dominant and ubiquitination-reinforced mechanism in SEPTIN7-mediated FGFR4 activity.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure 9 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
A phosphorylation-dominant and ubiquitination-reinforced mechanism in SEPTIN7-mediated FGFR4 activity.
Open Access
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
Supplementary Table 1 List of Abbreviations.
Website
Google Scholar
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 1 from SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling
by Tifan Sun, Qiruo Sun, Xueyan Zhang, Chenxi Wang, Tianen Chen, Mingyu Wu, Xiao Yang, Chengdian Rao, Yanxu Zhu, Lulu Zhang, et al.
Supplementary Table 1 List of Abbreviations.

Show all